These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9810347)

  • 1. [The no-reflow phenomenon: its incidence and clinical characteristics in a series of cases].
    Vallejo E; Peña-Duque MA; Noroño O; Ban Hayashi E; Gaspar J; Villavicencio R; Martínez Ríos MA
    Arch Inst Cardiol Mex; 1998; 68(3):247-52. PubMed ID: 9810347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute anterior myocardial infarction: increased dye intensity in the myocardial risk area after coronary angioplasty is associated with reduction of diastolic volumes.
    Destro G; Marino P; Carletti M; Barbieri E; Sesana M; Golia G; Anselmi M; Zardini P
    Cardiologia; 1999 Dec; 44(12):1039-46. PubMed ID: 10687253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [No-reflow phenomenon occurring during elective angioplasty performed due to in-stent restenosis -- a case report].
    Dobrzycki S; Nowak K; Kozuch M; Bachórzewska-Gajewska H; Poniatowski B; Zuk J
    Kardiol Pol; 2006 Apr; 64(4):437-40. PubMed ID: 16699996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
    Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No reflow phenomenon in coronary heart disease.
    Ito H
    J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
    Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
    Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.
    Lee CH; Wong HB; Tan HC; Zhang JJ; Teo SG; Ong HY; Low A; Sutandar A; Lim YT
    J Interv Cardiol; 2005 Aug; 18(4):261-6. PubMed ID: 16115155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization.
    Niccoli G; Lanza GA; Shaw S; Romagnoli E; Gioia D; Burzotta F; Trani C; Mazzari MA; Mongiardo R; De Vita M; Rebuzzi AG; Lüscher TF; Crea F
    Eur Heart J; 2006 Aug; 27(15):1793-8. PubMed ID: 16829540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is Q-wave on admission associated with microvascular injury in patients with acute myocardial infarction treated with primary angioplasty?].
    Dobrzycki S; Korecki J; Kozuch M; Kamiński K; Latocha-Korecka G; Poniatowski B; Filipczuk P; Mazur M; Gorlo A; Musiał WJ
    Przegl Lek; 2004; 61(9):891-4. PubMed ID: 15803893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revascularization of left anterior descending artery with drug-eluting stents: comparison with off-pump surgery.
    Herz I; Moshkovitz Y; Hendler A; Adam SZ; Uretzky G; Ben-Gal Y; Mohr R
    Ann Thorac Surg; 2005 Jan; 79(1):88-92. PubMed ID: 15620921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of distal embolization and no-reflow in patients with acute myocardial infarction and total occlusion in the infarct-related vessel: a subgroup analysis of the cohort of acute revascularization in myocardial infarction with excimer laser-CARMEL multicenter study.
    Dahm JB; Ebersole D; Das T; Madyhoon H; Vora K; Baker J; Hilton D; Topaz O
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):67-74. PubMed ID: 15619312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary aspiration for bailout management of the no-reflow during percutaneous coronary intervention.
    Min PK; Ko YG; Jang Y
    Int J Cardiol; 2006 May; 109(3):402-5. PubMed ID: 15967519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study.
    Tanaka A; Imanishi T; Kitabata H; Kubo T; Takarada S; Tanimoto T; Kuroi A; Tsujioka H; Ikejima H; Komukai K; Kataiwa H; Okouchi K; Kashiwaghi M; Ishibashi K; Matsumoto H; Takemoto K; Nakamura N; Hirata K; Mizukoshi M; Akasaka T
    Eur Heart J; 2009 Jun; 30(11):1348-55. PubMed ID: 19383736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.
    Barcin C; Denktas AE; Lennon RJ; Hammes L; Higano ST; Holmes DR; Garratt KN; Lerman A
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):484-91. PubMed ID: 15065143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary angioplasty for cardiogenic shock complicating acute myocardial infarction.
    Calton R; Jaison TM; David T
    Indian Heart J; 1999; 51(1):47-54. PubMed ID: 10327779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.
    Sakuma T; Leong-Poi H; Fisher NG; Goodman NC; Kaul S
    J Am Soc Echocardiogr; 2003 Jan; 16(1):15-21. PubMed ID: 12514630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.